Diagnosis and Treatment of Anxiety Disorders
The most effective approach for diagnosing and treating anxiety disorders involves standardized screening with validated tools like the GAD-7, followed by a comprehensive assessment to confirm diagnosis, and treatment with cognitive behavioral therapy (CBT) as first-line therapy, with selective serotonin reuptake inhibitors (SSRIs) as first-line pharmacotherapy when needed. 1, 2
Diagnostic Approach
Initial Screening
- Use standardized screening instruments such as the Generalized Anxiety Disorder-7 (GAD-7) scale to identify anxiety concerns, with scores categorized as mild (0-9), moderate (10-14), and moderate to severe/severe (15-21) 1
- The GAD-7 has good internal consistency and convergent validity with worry, anxiety, depression, and stress, though specificity may be limited in some populations 3
- Consider using the shorter GAD-2 for initial screening, which has similar diagnostic accuracy to the GAD-7 for detecting both generalized anxiety disorder and any anxiety disorder 4
Comprehensive Assessment
- Conduct interviews with both the patient and collateral sources (with patient consent) including family members, teachers, and primary care providers to gather comprehensive diagnostic information 1
- Distinguish clinically significant anxiety from everyday worries and fears, and rule out medical conditions that can present with anxiety symptoms (thyroid disorders, respiratory disorders, metabolic conditions) 1
- Assess for comorbid conditions, particularly depression, as anxiety disorders frequently co-occur with depressive disorders 1, 5
Differential Diagnosis
- Evaluate for specific anxiety disorders according to DSM-5 criteria: Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Specific Phobia, Separation Anxiety Disorder, and Agoraphobia 1
- Consider appropriate laboratory testing (e.g., glucose, thyroid function) in collaboration with primary care if medical conditions are suspected 1
Treatment Approaches
Treatment Selection Based on Severity
- For mild anxiety symptoms (GAD-7 score 0-9): Provide education, active monitoring, self-help resources based on CBT principles, and structured physical activity 1
- For moderate anxiety symptoms (GAD-7 score 10-14): Refer to educational and support services and consider low-intensity psychological interventions 1
- For moderate to severe/severe anxiety symptoms (GAD-7 score 15-21): Implement high-intensity interventions including CBT, behavioral activation, structured physical activity, and consider pharmacotherapy 1
Psychological Interventions
- Cognitive Behavioral Therapy (CBT) is the psychological treatment with the strongest evidence of efficacy for anxiety disorders and should be considered first-line treatment 1, 2
- The majority of psychological interventions are offered individually, face-to-face (52.3%), with some using combined in-person and telephone format 5
- Key components of CBT for anxiety include psychoeducation, diaphragmatic breathing techniques, and in vivo exposure to feared situations 6
- For patients with symptoms of both depression and anxiety, treatment of depressive symptoms should be prioritized or a unified protocol combining CBT treatments for both conditions may be used 5
Pharmacological Interventions
- Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are first-line medications for pharmacotherapy of anxiety disorders 1, 2, 7
- Sertraline (an SSRI) is FDA-approved for various anxiety disorders including panic disorder, social anxiety disorder, and PTSD, with dosing typically starting at 50mg daily and titrated as needed 8
- Benzodiazepines can be effective for acute symptom management but carry risk of dependence and are not recommended for routine use 6, 7
- After remission, medications should be continued for 6 to 12 months to prevent relapse 7, 9
Monitoring and Follow-up
- Regularly assess treatment response using standardized measures (e.g., at pretreatment, 4 weeks, 8 weeks, and end of treatment) 5
- If pharmacologic treatment is used, regularly assess (e.g., 4 and 8 weeks) symptom relief, side effects, and patient satisfaction 5
- After 8 weeks of treatment, if there is little improvement despite good adherence, adjust the regimen (e.g., add psychological or pharmacologic intervention, change medication, or switch from group to individual therapy) 5
Special Considerations
- Only about 20% of people with anxiety disorders seek care, highlighting the importance of proactive screening 1
- Cautiousness and avoidance are cardinal features of anxiety, which may lead to poor follow-through with treatment recommendations 1
- Cultural adaptations to CBT may be necessary, including incorporating mindfulness techniques for Asian Americans, addressing culturally specific manifestations of anxiety for Hispanic/Latino patients, and emphasizing in vivo exposure for African Americans 6
- For patients with comorbid anxiety and depression, treatment of depressive symptoms should be prioritized 5
Treatment Efficacy
- Overall, 65.9% of psychological interventions report effectiveness in reducing anxiety symptoms by the end of treatment, with 77.8% maintaining treatment gains at follow-up 5
- Meta-analyses suggest that SSRIs and SNRIs are associated with small to medium effect sizes compared with placebo for various anxiety disorders 2
- CBT has shown large effect sizes for generalized anxiety disorder and small to medium effects for social anxiety disorder and panic disorder compared to psychological or pill placebo 2
- Combined treatment with CBT and SSRI medication has shown superior outcomes compared to either treatment alone 10